IRIS PubliCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.667
NA - Nord America 1.449
AS - Asia 571
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 3.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.438
DE - Germania 498
SE - Svezia 368
IT - Italia 262
SG - Singapore 210
CN - Cina 189
IE - Irlanda 124
UA - Ucraina 106
ID - Indonesia 77
RU - Federazione Russa 61
FR - Francia 59
GB - Regno Unito 58
FI - Finlandia 47
IN - India 45
BE - Belgio 28
TR - Turchia 18
HK - Hong Kong 10
PL - Polonia 10
CA - Canada 9
CZ - Repubblica Ceca 8
IR - Iran 7
JP - Giappone 6
NL - Olanda 6
RO - Romania 6
CH - Svizzera 5
CI - Costa d'Avorio 5
DK - Danimarca 5
GR - Grecia 5
AU - Australia 4
EU - Europa 4
ES - Italia 3
LT - Lituania 3
IL - Israele 2
PE - Perù 2
RE - Reunion 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
BZ - Belize 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
KG - Kirghizistan 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 3.707
Salva come PNG Salva come JPEG
Città #
Chandler 322
Singapore 173
Ashburn 147
Dublin 124
Jakarta 75
New York 69
Rome 69
Jacksonville 60
Milan 52
San Mateo 51
Wilmington 46
Nanjing 44
Cattolica 41
Chicago 37
Boston 36
Dearborn 35
Moscow 33
Marseille 31
Helsinki 29
Brussels 28
Princeton 28
Munich 24
Ann Arbor 22
Los Angeles 19
Nürnberg 19
Woodbridge 19
Beijing 18
Redwood City 17
Saint Petersburg 17
Augusta 15
Izmir 15
Nanchang 15
Bremen 14
Falls Church 13
Changsha 11
Seattle 11
Hebei 10
Kraków 10
Norwalk 10
Shenyang 10
Tianjin 10
Boardman 9
Fairfield 9
Kunming 8
Lawrence 8
London 8
Brno 7
Hong Kong 7
Houston 7
Falkenstein 6
Lancaster 6
Leawood 6
Portland 6
Washington 6
Abidjan 5
Frankfurt am Main 5
Fremont 5
Guangzhou 5
Jiaxing 5
Nuremberg 5
Zhengzhou 5
Amsterdam 4
Athens 4
Atlanta 4
Edinburgh 4
Jinan 4
Mountain View 4
Ottawa 4
Pune 4
San Diego 4
Santa Clara 4
Toronto 4
University Park 4
Andover 3
Casalecchio di Reno 3
Genoa 3
Hangzhou 3
Hounslow 3
Kish 3
Palermo 3
Paris 3
Simi Valley 3
Taizhou 3
Zurich 3
Boydton 2
Brescia 2
Buffalo 2
Cantagallo 2
Chiswick 2
Clayton 2
Como 2
Copenhagen 2
Dallas 2
Fontanelle 2
Jodhpur 2
Köln 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Lima 2
Totale 2.070
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 206
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 181
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 157
Vanishing-recurrent benign liver lesions 115
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 113
[The treatment of hepatocellular carcinoma: an update] 106
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 105
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 100
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 99
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 93
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 93
Liver transplantation in patients with alcoholic liver disease: A retrospective study 92
Severe giant cell arteritis associated with essential thrombocythaemia. 87
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 86
A giant calcified hepatic mass 77
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 77
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 75
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 74
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 68
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 68
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 66
Acute HEV hepatitis: clinical and laboratory diagnosis 61
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 60
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 56
Liver transplantation for drug-induced acute liver failure 56
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 54
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 53
Fatty liver and drugs: the two sides of the same coin 51
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 51
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 49
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 47
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 46
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 44
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 41
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 40
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 39
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 39
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 35
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 32
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 31
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 30
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 27
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 27
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 25
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 24
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 24
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 23
Clinical impact of comorbidities in an Italian NAFLD cohort 23
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 22
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 22
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 22
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 22
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 22
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 21
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 21
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 20
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 20
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 20
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 20
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 19
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 19
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 18
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 16
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 15
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 15
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 14
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 13
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 12
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 12
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 11
Abdominal angina 9
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 8
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 8
Totale 3.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020236 0 0 0 0 33 31 53 17 14 27 38 23
2020/2021245 4 25 10 35 38 10 25 9 33 13 36 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.075 132 110 55 144 93 159 64 94 104 33 69 18
2023/2024713 49 172 26 46 35 111 45 33 13 39 47 97
2024/2025339 30 29 126 55 99 0 0 0 0 0 0 0
Totale 3.787